Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. April 2022 13:31 ET | Quelle: OcyonBio (ocyonbio.com)

Biosimilar Solutions Initiates Registrational Clinical Trial for Biosimilar Version Neulasta

AGUADILLA, Puerto Rico, April 13, 2022 (GLOBE NEWSWIRE) -- OcyonBio, LLC's client Biosimilar Solutions, Inc., announces it has started its registrational clinical trials for the biosimilar version...
23. März 2022 12:00 ET | Quelle: OcyonBio (ocyonbio.com)

OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Biosimilar Product

AGUADILLA, Puerto Rico, March 23, 2022 (GLOBE NEWSWIRE) -- Biosimilar Solutions, Inc. announces it has started its registrational clinical trials for BSC1020®, a recombinant filgrastim product...
14. März 2022 11:46 ET | Quelle: OcyonBio (ocyonbio.com)

OcyonBio Announces Biosimilar Solutions to Begin GMP Manufacturing in Puerto Rico

AGUADILLA, Puerto Rico, March 14, 2022 (GLOBE NEWSWIRE) -- OcyonBio announces manufacturing and operations agreement to develop biosimilar drug product facilities for Biosimilar Solutions, Inc....
14. Februar 2022 12:00 ET | Quelle: OcyonBio (ocyonbio.com)

OcyonBio Appoints Ricardo Zayas as Chief Operating Officer

AGUADILLA, Puerto Rico, Feb. 14, 2022 (GLOBE NEWSWIRE) -- OcyonBio, LLC announces it has appointed Ricardo Zayas its Chief Operating Officer. OcyonBio is creating an advanced therapy contract...
25. Januar 2022 09:00 ET | Quelle: OcyonBio (ocyonbio.com)

OcyonBio Appoints Daniel Chang, CPA, MBA, CPMP, CPIM as Chief Financial Officer

AGUADILLA, Puerto Rico, Jan. 25, 2022 (GLOBE NEWSWIRE) -- OcyonBio, LLC announces it has appointed Daniel Chang Chief Financial Officer. OcyonBio is creating a contract development and manufacturing...